When viewing this topic in a different language, you may notice some differences in the way the content is structured, but it still reflects the latest evidence-based guidance.

Avian influenza A (H5N1) virus infection

Last reviewed: 21 Oct 2024
Last updated: 17 Oct 2024
17 Oct 2024

Further h​uman cases of bird flu associated with outbreak in poultry and dairy cattle in the US

Avian influenza A(H5N1) virus is currently causing a multistate outbreak in poultry and dairy cows in the US. While outbreaks have previously been reported in poultry, this is the first time the virus has been detected in cows. Cases of human infection linked to the outbreak in dairy cows have been reported, and these cases represent the first instances of likely mammal-to-human transmission globally.

As of 16 October 2024, 25 cases of human infection associated with exposure to infected poultry or dairy cows have been reported in 2024 across five states - Texas, Michigan, Colorado, Missouri, and California. Of the 25 cases, 15 occurred following exposure to infected dairy cows, 9 occurred following exposure to infected poultry, and 1 case had no known animal exposure. No deaths have been reported. Prior to this outbreak, the first and only human case of infection ever reported in the US was in 2022 in Colorado, and was associated with direct exposure to infected poultry during a culling process.[22]

Updated situation summaries are available from the Centers for Disease Control and Prevention (CDC), and are being updated regularly:

As part of the current outbreak, people with exposure to infected (or potentially infected) birds, cows, or other domestic or wild animals are being monitored and tested if they develop influenza-like symptoms. At least 5000 people with potential exposure have been monitored in the US since March 2024.​ The CDC currently considers the public health risk to be low.[22] In the UK, the UK Health Security Agency (UKHSA) considers the risk to the public to be very low.[36]

In light of the outbreak, the CDC has published interim guidelines for prevention, monitoring, and public health investigations.[37]

Members of the public are advised to:

  • Avoid close, long, or unprotected exposures to sick or dead animals, including wild birds, poultry, other domesticated birds, and other wild or domesticated animals (including cows).

  • Avoid unprotected exposures to animal feces, bedding/litter, unpasteurized (raw) milk or cheeses, or materials that have been touched by, or closely exposed to, birds or other animals with suspected or confirmed H5N1 virus infection.

Clinicians are advised to consider the possibility of HPAI A(H5N1) virus infection in anyone showing signs or symptoms of acute respiratory illness who has a relevant exposure history.

  • People are advised to monitor themselves for new respiratory illness symptoms, including conjunctivitis, for 10 days after their last exposure if they meet relevant epidemiologic criteria. Antiviral postexposure prophylaxis may be considered in certain people to prevent infection.

  • Symptomatic people are advised to seek prompt medical care for diagnosis and treatment, and isolate themselves away from others.

The CDC recommends oseltamivir as the first-line treatment in both symptomatic outpatients and hospitalized patients.[38]

Sporadic human cases of HPAI A(H5N1) infection have been reported since 1997, with a case fatality rate of more than 50% in reported cases. Most human infections have occurred after unprotected exposure to sick or dead infected poultry. There has been no evidence of sustained human-to-human transmission, and limited nonsustained human-to-human transmission has not been reported since 2007.

See Epidemiology

Original source of update

Summary

Definition

History and exam

Key diagnostic factors

  • cough
  • influenza-like illness
  • conjunctivitis
  • dyspnea
  • fever
  • rales, rhonchi
  • wheeze
  • decreased breath sounds
  • tachypnea
Full details

Other diagnostic factors

  • abdominal pain, vomiting, diarrhea
  • altered mental status
  • seizures
Full details

Risk factors

  • close contact with infected birds
  • close contact with other animals
  • recent travel to a county where HPAI-A(H5N1) virus has been detected in birds or other animals
  • environmental exposure to H5N1 virus
  • close contact with infected humans
  • laboratory work with H5N1 virus
Full details

Diagnostic tests

1st tests to order

  • CBC with differential
  • LFTs
  • chest x-ray
  • pulse oximetry
  • sputum Gram stain
  • sputum and blood bacterial culture
  • real-time reverse transcription polymerase chain reaction (rtRT-PCR)
Full details

Tests to consider

  • viral culture
Full details

Treatment algorithm

INITIAL

close contact of confirmed or probable case

ACUTE

suspected or probable or confirmed infection

Contributors

Authors

Timothy M. Uyeki, MD, MPH, MPP

Chief Medical Officer

Influenza Division

National Center for Immunization and Respiratory Diseases

Centers for Disease Control and Prevention

Atlanta

GA

Disclosures

TMU declares that he is an unpaid member and clinical Chair of the World Health Organization Guidelines Developmental Group: Clinical Management of Influenza Guidelines 2023-2024.

Acknowledgements

Dr Timothy M. Uyeki would like to gratefully acknowledge Dr Justin R. Ortiz, a previous contributor to this topic.

Disclosures

JRO declares that he has no competing interests.

Peer reviewers

Richard Martinello, MD

Professor

Departments of Internal Medicine and Pediatrics

Yale School of Medicine

New Haven

CT

Disclosures

RM declares that he has no competing interests.

An De Sutter, MD, PhD

Associate Professor

Department of General Practice and Primary Health Care

Ghent University

Belgium

Disclosures

ADS declares that she has no competing interests.

  • Differentials

    • Coronavirus disease 2019 (COVID-19)
    • Community-acquired pneumonia
    • Atypical pneumonia
    More Differentials
  • Guidelines

    • Highly pathogenic avian influenza A(H5N1) virus in animals: interim recommendations for prevention, monitoring, and public health investigations
    • Interim guidance on the use of antiviral medications for treatment of human infections with novel influenza A viruses associated with severe human disease
    More Guidelines
  • Patient information

    Flu

    Pneumonia

    More Patient information
  • padlock-lockedLog in or subscribe to access all of BMJ Best Practice

Use of this content is subject to our disclaimer